Created with Sketch.
14 minutes | Jun 30, 2022
GI Around the World: A Look at IBS in Asia
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Andrew Ong MBChB, MRCP, FAMS Irritable bowel syndrome (IBS) varies by geography, culture, and environment. So to learn more about IBS in the Asian population, Dr. Peter Buch welcomes Dr. Andrew Ong, who discusses the differences between IBS in the Asian population compared to North America and the importance of considering cultural differences when confronting IBS.
13 minutes | Jun 29, 2022
Navigating Non-Alcoholic Fatty Liver Disease: Diagnostic & Management Strategies
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Naim Alkhouri, MD Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the United States and affects about one-quarter of the population. So what are the risk factors for developing NAFLD, and how can we monitor its progression and manage our patients? Joining Dr. Peter Buch to answer these and other key questions is Dr. Naim Alkhouri, Chief of Transplant Hepatology and the Director of the Fatty Liver Program at Arizona Liver Health.
10 minutes | Jun 22, 2022
Reviewing the Use of Per-Oral Endoscopic Myotomy in Esophageal Dysmotility
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michel Kahaleh, MD Per-oral endoscopic myotomy (POEM) is a specialized endoscopic procedure to treat motility disorders of the esophagus. But what’s the procedure’s specific use in treating achalasia and other esophageal dysmotilities? To help answer that key question, Dr. Peter Buch is joined by Dr. Michel Kahaleh, Professor of Medicine and Director of the Pancreas Program in the Department of Medicine at Robert Wood Johnson Medical School, to discuss which patients to consider for POEM and key limitations of the procedure that clinicians should be aware of.
13 minutes | Jun 22, 2022
Scrubs & Heels: How an Organization Aims to Close Gender Disparities in GI
Host: Neilanjan Nandi, MD Guest: Anita Afzali MD, MPH, FACG, AGAF Guest: Aline Charabaty, MD Although the rate of females in gastroenterology has increased, gender disparities such as equal pay and leadership positions still persist. That’s why Drs. Aline Charabaty and Anita Afzali co-founded Scrubs & Heels, a leadership organization working to foster professional growth for women in gastroenterology. And now, they join Dr. Neil Nandi to discuss Scrubs & Heels’ mission and how we can close gender disparities and promote women in the field of gastroenterology.
15 minutes | Jun 14, 2022
Assessing Anticoagulants & Antiplatelets During GI Bleeding
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Neena Abraham, MD, MS Join Dr. Peter Buch as he explores the management of acute gastrointestinal bleeding and the periendoscopic period with anticoagulants and with Dr. Neena Abraham, Associate Medical Director at the Mayo Clinic Center for the Science of Health Care Delivery in Arizona and lead author of the joint “American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline.”
12 minutes | Jun 13, 2022
Fighting Food Allergies & Intolerances in GI
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Frances Onyimba, MD Over the last two decades, up to 20 percent of the population in industrialized nations have reported an abnormal physical response to food ingestion, also known as an adverse reaction to food. So what key information do we need to know about food allergies and intolerances amid this recent rise around the world? To find out, Dr. Peter Buch is joined by Dr. Frances Onyimba, Assistant Professor of Medicine at the University of Maryland School of Medicine. Together, they’ll discuss how we can better identify and diagnose food allergies and intolerances.
11 minutes | Jun 13, 2022
A Guide for Deprescribing Proton Pump Inhibitors
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Laura Targownik, MD Proton pump inhibitors (PPIs) are among the 10 most widely prescribed medications, but PPI overuse has been associated with adverse events. So what is the best advice for de-prescribing PPIs, and which of our patients should remain on PPIs? Find out the answers to these and other key questions with Dr. Peter Buch and Dr. Laura Targownik, who’s the lead author of the American Gastroenterological Association’s Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors.
10 minutes | Jun 6, 2022
Assessing the Availability of H. Pylori Testing
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Graham, MD H. pylori testing is accessible now more than ever before. Why is this development so important? To help us understand why, Dr. David Graham, a Professor of Medicine and Gastroenterology at the Baylor College of Medicine, joins Dr. Peter Buch to discuss this availability and dive into “Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why."
12 minutes | Jun 2, 2022
How to Best Manage Acute-on-Chronic Liver Failure
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jasmohan Bajaj, MD In patients with cirrhosis and chronic liver disease, acute-on-chronic liver failure is emerging as a major cause of mortality. That’s why an update on precipitating factors and essential management strategies is the basis of Dr. Peter Buch’s discussion with Dr. Jasmohan Bajaj, Professor of Medicine at the Richmond VA Medical Center and lead author of the article “Acute-on-Chronic Liver Failure Clinical Guidelines,” which was published in the American Journal of Gastroenterology in February 2022.
14 minutes | May 27, 2022
Diving into the Science & Art Behind GERD Treatment
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Harish Gagneja, MD What are some ways we can strike the perfect balance when it comes to treating our patients with GERD? To help us answer this question, Dr. Harish Gagneja from the Dell Medical School at the University of Texas joins Dr. Peter Buch to explore balanced treatment options for these patients.
12 minutes | May 27, 2022
A Look at Emerging Virtual Reality Tools in Gastroenterology
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brennan Spiegel, MD, MSHS Let’s escape our busy day for a moment to imagine the future of gastroenterology and to ask ourselves: How can technology make us better clinicians? Explore that very question with Drs. Peter Buch and Brennan Spiegel as they discuss the latest advances in artificial intelligence and virtual reality that are aiding both clinical practice and research efforts.
10 minutes | May 23, 2022
Breaking Down Our Approach to Small Intestinal Bacterial Overgrowth
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexander Perelman, D.O. Small intestinal bacterial overgrowth (SIBO) has been recognized for years, yet the optimal method of diagnosis remains controversial. So to help clear up the controversy, Dr. Peter Buch welcomes back returning guest Dr. Alexander Perelman to talk about diagnosing and treating SIBO.
12 minutes | May 19, 2022
Evaluating Therapeutic Drug Monitoring in IBD
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Adam S. Cheifetz, MD Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
11 minutes | May 10, 2022
Gender & the Gut: Managing Women’s Digestive Health
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Asma Khapra, MD Over the last few years, we've only started to gain an understanding of how gender affects our approach to GI illnesses. And since a greater awareness of these differences will help us become better clinicians, Dr. Peter Buch speaks with Dr. Asma Khapra about how we can optimize our approach to managing common GI illnesses in our female patients.
12 minutes | Apr 21, 2022
Investigating the Latest Innovations in IBD
Host: Neilanjan Nandi, MD Guest: Peter D. Higgins, MDm PhD What's on the horizon for the management of inflammatory bowel disease? To share some of the latest clinical trial updates, Dr. Neil Nandi is joined by Dr. Peter Higgins from the University of Michigan to explore some of the latest developments in early detection tools and treatment strategies for patients with IBD.
9 minutes | Apr 20, 2022
ICIs & Gastrointestinal Side Effects: What You Need to Know
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Rashid N. Lui, MD Immune checkpoint inhibitors have evolved the treatment landscape for cancer, but we need to consider the GI side effects. To do so, Dr. Peter Buch is joined by Dr. Rashid N. Lui to assess the GI impacts of ICIs and how to manage them.
12 minutes | Apr 20, 2022
How to Mitigate the Risk of Medical Malpractice Claims
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael L. Weinstein, MD As clinicians, providing the best quality of care is paramount. But when it comes to procedure-intensive specialties, medical malpractice is a notable concern. So what do we need to know about the common malpractice claims in the GI field, and how can we mitigate the risk of those claims? To find out, Dr. Peter Buch is joined by Dr. Michael Weinstein, President and CEO of Capital Digestive Care.
13 minutes | Apr 18, 2022
Proton Pump Inhibitors: Overused or Necessary?
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexander Perelman, D.O. Proton pump inhibitors (PPIs) are among the most frequently prescribed medications in the world, but in many instances, they may be unnecessary. So how might this impact our patients’ health, and how can we identify those patients who should be prescribed PPIs? Dr. Peter Buch is joined by Dr. Alexander Perelman to talk about the overuse of PPIs.
11 minutes | Apr 12, 2022
Progress in Primary Biliary Cholangitis Care: A Look at Management Updates
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hetal A. Karsan, MD, FACG, FAASLD, FASGE, FACP Primary biliary cholangitis, which was formerly known as primary biliary cirrhosis, is a chronic disease that progresses over time. Fortunately, much progress has been made in that many patients are being diagnosed and treated much earlier than before. But what exactly has changed when it comes to our detection and treatment of this disease? Dr. Peter Buch is joined by Dr. Hetal Karsan, Adjunct Professor of Medicine in the Division of Digestive Diseases at Emory University School of Medicine, to discuss key updates in primary biliary cholangitis care.
11 minutes | Apr 11, 2022
Understanding IBD in Underserved Populations
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Lea Ann Chen, MD As clinicians, we know that adherence to treatment regimens is associated with improved outcomes in our patients with inflammatory bowel disease (IBD). However, many factors can contribute to a patient's nonadherence, and understanding what those factors are, especially in underserved patient populations, is an important category of care that we need to keep in mind. Tune in to hear Dr. Peter Buch speak with Dr. Lea Ann Chen about how we can manage IBD in underserved patient populations.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022